Results 271 to 280 of about 12,584 (301)
Some of the next articles are maybe not open access.
Continuum, 2011
: Numerous studies have been conducted in the past decade evaluating the use of statins and other lipid therapies for reducing vascular events. These studies have impacted the area of stroke prevention.: For patients with established coronary artery disease, statins reduce the rate of stroke. High-dose statin treatment has also been found to reduce the
Pratik, Bhattacharya +1 more
openaire +2 more sources
: Numerous studies have been conducted in the past decade evaluating the use of statins and other lipid therapies for reducing vascular events. These studies have impacted the area of stroke prevention.: For patients with established coronary artery disease, statins reduce the rate of stroke. High-dose statin treatment has also been found to reduce the
Pratik, Bhattacharya +1 more
openaire +2 more sources
Heart Disease, 2002
Dyslipidemia is recognized as a significant risk factor for atherosclerotic disease. There has been a great deal of progress in the detection and management of dyslipidemia, but challenges remain, including whether to treat children, adolescents, and the elderly.
openaire +2 more sources
Dyslipidemia is recognized as a significant risk factor for atherosclerotic disease. There has been a great deal of progress in the detection and management of dyslipidemia, but challenges remain, including whether to treat children, adolescents, and the elderly.
openaire +2 more sources
Atherosclerosis Supplements, 2002
By the year 2025, there will be more than 300 million type 2 diabetes sufferers worldwide. This epidemic will be followed by a wave of cardiovascular disease. Diabetes is in fact a serious vascular disease with poor prognosis, and not only a disease characterized by elevated blood glucose.
openaire +2 more sources
By the year 2025, there will be more than 300 million type 2 diabetes sufferers worldwide. This epidemic will be followed by a wave of cardiovascular disease. Diabetes is in fact a serious vascular disease with poor prognosis, and not only a disease characterized by elevated blood glucose.
openaire +2 more sources
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
Dyslipidemia is defined by abnormal levels of plasma lipoproteins. Several different types of dyslipidemia can be distinguished. An important group of drugs used in the treatment of dyslipidemia are the fibrates. Fibrates serve as agonists for the peroxisome proliferator-activated receptor alpha (PPAR¿), a ligand-activated transcription factor that ...
Duval, C.N.C. +2 more
openaire +1 more source
Dyslipidemia is defined by abnormal levels of plasma lipoproteins. Several different types of dyslipidemia can be distinguished. An important group of drugs used in the treatment of dyslipidemia are the fibrates. Fibrates serve as agonists for the peroxisome proliferator-activated receptor alpha (PPAR¿), a ligand-activated transcription factor that ...
Duval, C.N.C. +2 more
openaire +1 more source
American Journal of Health-System Pharmacy, 2010
The efficacy and safety of phytosterols for the management of dyslipidemia are reviewed.Phytosterols have been evaluated in over 40 clinical trials. The incorporation of 2 g of phytosterols daily into margarine, mayonnaise, orange juice, olive oil, low-fat milk, yogurt, and tablets is associated with significant reductions in low-density-lipoprotein ...
Jennifer M, Malinowski, Monica M, Gehret
openaire +2 more sources
The efficacy and safety of phytosterols for the management of dyslipidemia are reviewed.Phytosterols have been evaluated in over 40 clinical trials. The incorporation of 2 g of phytosterols daily into margarine, mayonnaise, orange juice, olive oil, low-fat milk, yogurt, and tablets is associated with significant reductions in low-density-lipoprotein ...
Jennifer M, Malinowski, Monica M, Gehret
openaire +2 more sources
Hypercholesterolemia and dyslipidemia
Current Treatment Options in Cardiovascular Medicine, 2000Disorders of cholesterol and lipoprotein metabolism are at the heart of atherosclerosis and coronary artery disease (CAD). CAD, however, is a metabolic disorder that involves a complex interaction between genetic susceptibility and environmental conditions.
openaire +2 more sources
The American Journal of Medicine, 2002
The 2 principal approaches to management of dyslipidemias are lifestyle intervention and lipid-modifying drug therapy. Recent revisions to the American Heart Association's dietary guidelines for reducing cardiovascular disease emphasize an overall healthy eating pattern and maintenance of appropriate body weight, together with achieving a desirable ...
openaire +2 more sources
The 2 principal approaches to management of dyslipidemias are lifestyle intervention and lipid-modifying drug therapy. Recent revisions to the American Heart Association's dietary guidelines for reducing cardiovascular disease emphasize an overall healthy eating pattern and maintenance of appropriate body weight, together with achieving a desirable ...
openaire +2 more sources
The American Journal of Cardiology, 1998
Usual risk factors for coronary artery disease account for only 25-50% of increased atherosclerotic risk in diabetes mellitus. Other obvious risk factors are hyperglycemia and dyslipidemia. However, hyperglycemia is a very late stage in the sequence of events from insulin resistance to frank diabetes, whereas lipoprotein abnormalities are manifested ...
openaire +2 more sources
Usual risk factors for coronary artery disease account for only 25-50% of increased atherosclerotic risk in diabetes mellitus. Other obvious risk factors are hyperglycemia and dyslipidemia. However, hyperglycemia is a very late stage in the sequence of events from insulin resistance to frank diabetes, whereas lipoprotein abnormalities are manifested ...
openaire +2 more sources
Steroids, 2012
Life-long apolipoprotein lipid metabolic dysfunction in women with PCOS exaggerates the risk for cardiovascular disease (CVD) with aging. The dysfunction has involved insulin resistance (IR), which occurs in most women with PCOS. Women with PCOS have androgen excess, IR, variable amounts of estrogen exposure, and many environmental factors, all of ...
openaire +2 more sources
Life-long apolipoprotein lipid metabolic dysfunction in women with PCOS exaggerates the risk for cardiovascular disease (CVD) with aging. The dysfunction has involved insulin resistance (IR), which occurs in most women with PCOS. Women with PCOS have androgen excess, IR, variable amounts of estrogen exposure, and many environmental factors, all of ...
openaire +2 more sources
2012
Abstract Abnormal cholesterol and lipoprotein metabolism, together with endothelial injury are the major progenitors of atherosclerosis, the leading cause of obstructive coronary artery and vascular diseases worldwide. Dyslipidemia in particular is considered an essential risk factor because atherosclerotic plaques are formed in large ...
Joseph G. Murphy +2 more
openaire +1 more source
Abstract Abnormal cholesterol and lipoprotein metabolism, together with endothelial injury are the major progenitors of atherosclerosis, the leading cause of obstructive coronary artery and vascular diseases worldwide. Dyslipidemia in particular is considered an essential risk factor because atherosclerotic plaques are formed in large ...
Joseph G. Murphy +2 more
openaire +1 more source